Urology News and Research

Latest Urology News and Research

Research reveals how cancer-causing gene influences genetic variability in prostate cancer

Researchers from Barts Cancer Institute (BCI) at Queen Mary University of London, the Italian Institute for Genomic Medicine, and the University of Milan have identified a novel role for a cancer-causing gene in controlling an important genetic process that underpins genetic variation in prostate cancer.

27 Sep 2022

Regular marijuana use may increase the risk of overactive bladder

Regular users of marijuana were at a greater risk of developing and suffering from severe overactive bladder disorder.

27 Sep 2022

Knowledge of bladder cancer is alarmingly low among European adults, survey finds

Europe has some of the highest incidence rates of bladder cancer around the world, yet knowledge of the disease is still alarmingly low according to a new survey from the European Association of Urology.

26 Sep 2022

Mount Sinai researchers use unbiased AI-based method to study the causes of cognitive impairment

Mount Sinai researchers have used novel artificial intelligence methods to examine structural and cellular features of human brain tissues to help determine the causes of Alzheimer's disease and other related disorders.

21 Sep 2022

Study investigates the link between protein intake and skeletal muscle mass in kidney transplant recipients

Conventional wisdom holds that low protein intake is essential for kidney disease patients. However, scientists from Osaka Metropolitan University demonstrated that it might not always be the case with their recent study on the relationship between protein intake and skeletal muscle mass in kidney transplant recipients.

16 Sep 2022

Winners of the 2022 CURE-19 Research Pilot Grants announced

The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai and NYC Health + Hospitals have announced the 2022 awardees of the CURE-19 Research Pilot Grants, an initiative to support collaborative, interdisciplinary COVID-19 research that will address both the pandemic and root causes of health disparities in New York City.

14 Sep 2022

Oral anticoagulant drug may be safe, effective in preventing blood clots after urologic cancer surgery

The oral anticoagulant drug apixaban may offer a safer, more effective alternative to standard home heparin injections for patients taking extended prophylaxis (EP) to prevent blood-clot-related complications after surgery, reports a study in The Journal of Urology, an Official Journal of the American Urological Association.

12 Sep 2022

Neoadjuvant NHAs followed by surgery can improve key outcomes in high-risk prostate cancer patients

For high-risk patients with prostate cancer, treatment with novel hormonal agents (NHAs) followed by surgery can reduce the risk of recurrent and progressive cancer, compared to initial treatment with surgery, suggests a study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA).

12 Sep 2022

Research could lead to a new therapeutic option for patients with bladder cancer

Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system.

12 Sep 2022

Novel tests detect common cancer signals across over 50 types of cancer

Cancer doctors, care providers and payers need to get ready for a major shift in early cancer detection that will affect almost every stage of cancer diagnosis and treatment. New data supporting the accuracy of multi-cancer early detection (MCED) blood testing (1), presented at the ESMO Congress 2022, have major implications for future cancer care provision, said Fabrice André, ESMO 2022 Scientific Co-Chair.

12 Sep 2022

How does SARS-CoV-2 affect the male genitourinary system?

In a recent paper published in the American Journal of Clinical and Experimental Urology, researchers reviewed existing data on the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on the male genitourinary (GU) tract.

7 Sep 2022

Low-dose ketamine is safe and effective to treat children with ADNP syndrome, study suggests

Results of a small, but unique research study, led by researchers from the Seaver Autism Center for Research and Treatment at Mount Sinai and published online in Human Genetics and Genomic Advances, suggest that low-dose ketamine is generally safe, well-tolerated and effective to treat clinical symptoms in children diagnosed with ADNP syndrome (also known as Helsmoortel-VanDerAa syndrome), a rare neurodevelopmental disorder caused by mutations in the activity dependent neuroprotective protein (ADNP) gene.

6 Sep 2022

Study shows encouraging therapeutic options for patients with relapsed multiple myeloma

Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails.

1 Sep 2022

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

A large-scale international study led by Mount Sinai has yielded the first risk score that can help predict mortality for patients with atrial fibrillation (AFib) who have undergone a successful transcatheter aortic valve replacement (TAVR) and discharged home.

29 Aug 2022

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.

26 Aug 2022

More than 50 new surgical hubs will open for tacking the Covid backlogs

Over 50 new surgical hubs will open across the country to help bust the Covid backlogs and offer hundreds of thousands more patients quicker access to vital procedures, the Health and Social Care Secretary Steve Barclay has announced today.

25 Aug 2022

Study suggests no lasting setback for urologists in training after COVID-19 pandemic

After the onset of the COVID-19 pandemic, urology training programs saw a precipitous drop in opportunities for residents to gain hands-on surgical experience, reports a study in Urology Practice, an Official Journal of the American Urological Association. The journal is published in the Lippincott portfolio by Wolters Kluwer.

24 Aug 2022

Urology News and Research

Latest Urology News and Research

Research reveals how cancer-causing gene influences genetic variability in prostate cancer

Regular marijuana use may increase the risk of overactive bladder

Knowledge of bladder cancer is alarmingly low among European adults, survey finds

Mount Sinai researchers use unbiased AI-based method to study the causes of cognitive impairment

Study investigates the link between protein intake and skeletal muscle mass in kidney transplant recipients

Winners of the 2022 CURE-19 Research Pilot Grants announced

Oral anticoagulant drug may be safe, effective in preventing blood clots after urologic cancer surgery

Neoadjuvant NHAs followed by surgery can improve key outcomes in high-risk prostate cancer patients

Research could lead to a new therapeutic option for patients with bladder cancer

Novel tests detect common cancer signals across over 50 types of cancer

How does SARS-CoV-2 affect the male genitourinary system?

Low-dose ketamine is safe and effective to treat children with ADNP syndrome, study suggests

Study shows encouraging therapeutic options for patients with relapsed multiple myeloma

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

More than 50 new surgical hubs will open for tacking the Covid backlogs

Study suggests no lasting setback for urologists in training after COVID-19 pandemic

Case report on the post-orgasmic illness treated with antihistamines

New preclinical drug candidate shows promise in eradicating gonorrhea bacteria

Study shows encouraging results for robotic IVC thrombectomy

Pioneering new medical imaging solutions

Pioneering new medical imaging solutions

Using human iPSC-derived cells to revolutionize the field of neurodegenerative disease

Antibodies eBook

Urology News and Research

Latest Urology News and Research

Pioneering new medical imaging solutions

Pioneering new medical imaging solutions

Using human iPSC-derived cells to revolutionize the field of neurodegenerative disease

Antibodies eBook

Newsletters you may be interested in